Nanopharmaceutics: Part I—Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU

The latest advances in pharmaceutical technology are leading to the development of cutting edged approaches to produce what is now known as the “Holy Grail” of medicine—nanopharmaceutics. Over the latest decade, the pharmaceutical industry has made important contributions to the scale up of these ne...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pharmaceutics
Autors principals: Souto, Eliana B., Silva, Gabriela F., Dias-Ferreira, João, Zielinska, Aleksandra, Ventura, Fátima, Durazzo, Alessandra, Lucarini, Massimo, Novellino, Ettore, Santini, Antonello
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7076491/
https://ncbi.nlm.nih.gov/pubmed/32053962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12020146
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars